SCHEMBL8487351

SCHEMBL8487351

CCOC(=O)N1CCC(N2CCCC(=O)C2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.56
CHRM1 P11229 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TP53 P04637 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PKM P14618 1/20 0.48
GAA P10253 2/20 0.47
ALOX12 P18054 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
THRB P10828 1/20 0.47
ATM Q13315 1/20 0.47
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CHRM3 P20309 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8490392 0.82 CHRM1 (0.62) MAPK1CHRM1L3MBTL1TP53TDP1
SCHEMBL12967015 0.81 MAPK1 (0.70) MAPK1CHRM1L3MBTL1TP53TDP1
Hydrochloric Acid SCHEMBL8489849 0.80 MAPK1 (0.47) MAPK1CHRM1L3MBTL1MEN1KMT2A
SCHEMBL6306521 0.79 TSHR (0.44) MAPK1L3MBTL1MEN1KMT2ATDP1
SCHEMBL4516164 0.77 L3MBTL1 (0.52) MAPK1CHRM1L3MBTL1TP53TDP1
SCHEMBL4516367 0.76 TSHR (0.49) L3MBTL1MEN1KMT2ATDP1GAA
SCHEMBL21047822 0.75 L3MBTL3 (0.37) MAPK1L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL21047677 0.75 MAPK1 (0.40) MAPK1L3MBTL1MEN1KMT2A
SCHEMBL13243426 0.74 CHRM1 (0.52) MAPK1CHRM1L3MBTL1MEN1KMT2A
SCHEMBL8490717 0.74 CHRM1 (0.56) MAPK1CHRM1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032445-A1 OXIMINO-PIPERIDINE, -PYRROLIDINE AND -AZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MUSCARINIC RECEPTOR (ANT-)AGONISTS ALCON LABORATORIES, INC. (US) 1999-07-01 WO disclosed